Carregando...
Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering
Although chimeric antigen receptor (CAR)-engineered T cell therapy has achieved encouraging clinical trial results for treating hematological cancers, further optimization can likely expand this therapeutic success to more patients and other cancer types. Most CAR constructs used in clinical trials...
Na minha lista:
| Publicado no: | Mol Ther |
|---|---|
| Principais autores: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Gene & Cell Therapy
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5675441/ https://ncbi.nlm.nih.gov/pubmed/28784559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2017.07.009 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|